Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Exchange Rate Effect of -$400000.0 for Q1 2026, down 123.53% year-over-year from $1.7 million in Q1 2025, and down 1312.12% quarter-over-quarter from $33000.0 in Q4 2025.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at -$400000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 123.53% year-over-year to -$400000.0; the TTM figure through Mar 2026 stood at $4.5 million (up 158.56% YoY), while the FY2025 annual figure was $6.6 million, up 491.34% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$400000.0, down from $33000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.9 million in Q4 2022, with the low at -$5.4 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $33000.0 (2025), against an average of -$35588.2.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect tumbled 2332.35% in 2024, then jumped 708.56% in 2025.
- Jazz Pharmaceuticals' Exchange Rate Effect stood at $4.9 million in 2022, then sank by 63.75% to $1.8 million in 2023, then plunged by 227.95% to -$2.3 million in 2024, then jumped by 101.44% to $33000.0 in 2025, then plunged by 1312.12% to -$400000.0 in 2026.
- Business Quant data shows JAZZ's Exchange Rate Effect at -$400000.0 in Q1 2026, $33000.0 in Q4 2025, and $203000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn | -600,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -600,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 4.60 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | -759,000.00 |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 331,000.00 |
| Dec 31, 2022 | 4.94 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | -4.22 Mn |
| Mar 31, 2022 | -1.49 Mn |
| Dec 31, 2021 | -1.39 Mn |
| Sep 30, 2021 | -1.69 Mn |